Harbor Capital Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-60,304	Closed	-$1.29M	–	773
2023 Q4	$1.29M	Buy	60,304 +8,025	+15%	+$172K	0.25%	104
2023 Q3	$1.08M	Buy	52,279 +14,155	+37%	+$292K	0.23%	114
2023 Q2	$1.13M	Buy	+38,124	New	+$1.13M	0.23%	113